Ignite Creation Date:
2025-12-24 @ 5:15 PM
Ignite Modification Date:
2026-02-23 @ 4:30 AM
Study NCT ID:
NCT03976050
Status:
TERMINATED
Last Update Posted:
2020-11-18
First Post:
2019-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of HL-085 in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Kechow Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HL-085-US-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None